- Home
- DIOD vs CNTA Comparison
DIOD vs CNTA Comparison
Compare DIOD & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIOD
- CNTA
- Stock Information
- Founded
- DIOD 1959
- CNTA 2020
- Country
- DIOD United States
- CNTA United Kingdom
- Employees
- DIOD N/A
- CNTA N/A
- Industry
- DIOD Semiconductors
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- DIOD Technology
- CNTA Health Care
- Exchange
- DIOD Nasdaq
- CNTA Nasdaq
- Market Cap
- DIOD 2.5B
- CNTA 2.3B
- IPO Year
- DIOD N/A
- CNTA 2021
- Fundamental
- Price
- DIOD $54.63
- CNTA $23.03
- Analyst Decision
- DIOD Buy
- CNTA Strong Buy
- Analyst Count
- DIOD 2
- CNTA 8
- Target Price
- DIOD $57.50
- CNTA $31.29
- AVG Volume (30 Days)
- DIOD 339.7K
- CNTA 1.0M
- Earning Date
- DIOD 11-06-2025
- CNTA 11-11-2025
- Dividend Yield
- DIOD N/A
- CNTA N/A
- EPS Growth
- DIOD N/A
- CNTA N/A
- EPS
- DIOD 1.37
- CNTA N/A
- Revenue
- DIOD $1,387,702,000.00
- CNTA $15,000,000.00
- Revenue This Year
- DIOD $14.48
- CNTA N/A
- Revenue Next Year
- DIOD $8.39
- CNTA N/A
- P/E Ratio
- DIOD $39.60
- CNTA N/A
- Revenue Growth
- DIOD 2.86
- CNTA 118.88
- 52 Week Low
- DIOD $32.93
- CNTA $9.60
- 52 Week High
- DIOD $67.40
- CNTA $24.57
- Technical
- Relative Strength Index (RSI)
- DIOD 54.16
- CNTA 57.17
- Support Level
- DIOD $48.54
- CNTA $21.78
- Resistance Level
- DIOD $56.19
- CNTA $23.64
- Average True Range (ATR)
- DIOD 2.06
- CNTA 0.94
- MACD
- DIOD 0.33
- CNTA -0.24
- Stochastic Oscillator
- DIOD 79.01
- CNTA 40.50
About DIOD Diodes Incorporated
Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.